Returning from the afterlife? Sotorasib treatment for advanced KRAS mutant lung cancer: A case report

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

820

Figures (1-5)

103

Sum=950

Publishing Process of This Article

Item

Count

Browse

Download

109

Sum=177

Sep 6, 2024 (publication date) through Nov 12, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Sep 6, 2024; 12(25): 5805-5813
Published online Sep 6, 2024. doi: 10.12998/wjcc.v12.i25.5805

Full Size Figure Download Figure

Figure 4 Changes in tumor markers. A: Carcinoembryonic antigen (CEA) values; B: Carbohydrate antigen 125 (CA125) values.

Citation: Wang MX, Zhu P, Shi Y, Sun QM, Dong WH. Returning from the afterlife? Sotorasib treatment for advanced KRAS mutant lung cancer: A case report. World J Clin Cases 2024; 12(25): 5805-5813
URL: https://www.wjgnet.com/2307-8960/full/v12/i25/5805.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i25.5805